Efficacy and safety of radiofrequency in the treatment of hidradenitis suppurativa; a systematic review
Background and aims Hidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a minimally invasive method that acts by minimizing thermal damage to the dermis, resulting in collagen synthesis and scar improvement. We syst...
Saved in:
| Published in | Lasers in medical science Vol. 39; no. 1; p. 139 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Springer London
25.05.2024
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1435-604X 0268-8921 1435-604X |
| DOI | 10.1007/s10103-024-04077-0 |
Cover
| Abstract | Background and aims
Hidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a minimally invasive method that acts by minimizing thermal damage to the dermis, resulting in collagen synthesis and scar improvement. We systematically reviewed the efficacy and safety of RF in treating HS.
Methods
A systematic search was performed up to November 18th, 2023, in PubMed/Medline, Ovid Embase, and Web of Science. Clinical studies with English full texts were included. The National Institute of Health (NIH) Quality Assessment Tool for clinical trials and Methodological quality and synthesis of case series and case reports by Murad et al. were utilized for critical appraisal.
Results
Out of 55 identified studies, 11 met our inclusion criteria with 167 subjects who underwent RF therapy alone or combined with an intense pulsed laser (IPL), known as LAight®. LAight® significantly improved clinical outcomes in mild-to-moderate HS patients based on the Dermatology Life Quality Index (DLQI), International Hidradenitis Suppurativa Score System (IHS4), Pain-Numerical Rating Scale (NRS), and Hidradenitis Suppurativa Clinical Response (HiSCR). Moreover, RF therapy alone significantly alleviated the clinical manifestations in patients with mild-to-moderate HS. Additionally, fractional microneedling RF significantly decreased HS-associated inflammatory markers. RF was found to be safe with limited adverse events. However, in moderate-to-severe HS, RF has failed to yield satisfactory results.
Conclusion
RF is a safe energy-based method with promising outcomes, especially for long-term application in mild-to-moderate HS. In moderate-to-severe cases, RF should be combined with a systemic medication for further beneficial impacts. |
|---|---|
| AbstractList | Background and aims
Hidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a minimally invasive method that acts by minimizing thermal damage to the dermis, resulting in collagen synthesis and scar improvement. We systematically reviewed the efficacy and safety of RF in treating HS.
Methods
A systematic search was performed up to November 18th, 2023, in PubMed/Medline, Ovid Embase, and Web of Science. Clinical studies with English full texts were included. The National Institute of Health (NIH) Quality Assessment Tool for clinical trials and Methodological quality and synthesis of case series and case reports by Murad et al. were utilized for critical appraisal.
Results
Out of 55 identified studies, 11 met our inclusion criteria with 167 subjects who underwent RF therapy alone or combined with an intense pulsed laser (IPL), known as LAight®. LAight® significantly improved clinical outcomes in mild-to-moderate HS patients based on the Dermatology Life Quality Index (DLQI), International Hidradenitis Suppurativa Score System (IHS4), Pain-Numerical Rating Scale (NRS), and Hidradenitis Suppurativa Clinical Response (HiSCR). Moreover, RF therapy alone significantly alleviated the clinical manifestations in patients with mild-to-moderate HS. Additionally, fractional microneedling RF significantly decreased HS-associated inflammatory markers. RF was found to be safe with limited adverse events. However, in moderate-to-severe HS, RF has failed to yield satisfactory results.
Conclusion
RF is a safe energy-based method with promising outcomes, especially for long-term application in mild-to-moderate HS. In moderate-to-severe cases, RF should be combined with a systemic medication for further beneficial impacts. Hidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a minimally invasive method that acts by minimizing thermal damage to the dermis, resulting in collagen synthesis and scar improvement. We systematically reviewed the efficacy and safety of RF in treating HS. A systematic search was performed up to November 18th, 2023, in PubMed/Medline, Ovid Embase, and Web of Science. Clinical studies with English full texts were included. The National Institute of Health (NIH) Quality Assessment Tool for clinical trials and Methodological quality and synthesis of case series and case reports by Murad et al. were utilized for critical appraisal. Out of 55 identified studies, 11 met our inclusion criteria with 167 subjects who underwent RF therapy alone or combined with an intense pulsed laser (IPL), known as LAight®. LAight® significantly improved clinical outcomes in mild-to-moderate HS patients based on the Dermatology Life Quality Index (DLQI), International Hidradenitis Suppurativa Score System (IHS4), Pain-Numerical Rating Scale (NRS), and Hidradenitis Suppurativa Clinical Response (HiSCR). Moreover, RF therapy alone significantly alleviated the clinical manifestations in patients with mild-to-moderate HS. Additionally, fractional microneedling RF significantly decreased HS-associated inflammatory markers. RF was found to be safe with limited adverse events. However, in moderate-to-severe HS, RF has failed to yield satisfactory results. RF is a safe energy-based method with promising outcomes, especially for long-term application in mild-to-moderate HS. In moderate-to-severe cases, RF should be combined with a systemic medication for further beneficial impacts. Hidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a minimally invasive method that acts by minimizing thermal damage to the dermis, resulting in collagen synthesis and scar improvement. We systematically reviewed the efficacy and safety of RF in treating HS.BACKGROUND AND AIMSHidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a minimally invasive method that acts by minimizing thermal damage to the dermis, resulting in collagen synthesis and scar improvement. We systematically reviewed the efficacy and safety of RF in treating HS.A systematic search was performed up to November 18th, 2023, in PubMed/Medline, Ovid Embase, and Web of Science. Clinical studies with English full texts were included. The National Institute of Health (NIH) Quality Assessment Tool for clinical trials and Methodological quality and synthesis of case series and case reports by Murad et al. were utilized for critical appraisal.METHODSA systematic search was performed up to November 18th, 2023, in PubMed/Medline, Ovid Embase, and Web of Science. Clinical studies with English full texts were included. The National Institute of Health (NIH) Quality Assessment Tool for clinical trials and Methodological quality and synthesis of case series and case reports by Murad et al. were utilized for critical appraisal.Out of 55 identified studies, 11 met our inclusion criteria with 167 subjects who underwent RF therapy alone or combined with an intense pulsed laser (IPL), known as LAight®. LAight® significantly improved clinical outcomes in mild-to-moderate HS patients based on the Dermatology Life Quality Index (DLQI), International Hidradenitis Suppurativa Score System (IHS4), Pain-Numerical Rating Scale (NRS), and Hidradenitis Suppurativa Clinical Response (HiSCR). Moreover, RF therapy alone significantly alleviated the clinical manifestations in patients with mild-to-moderate HS. Additionally, fractional microneedling RF significantly decreased HS-associated inflammatory markers. RF was found to be safe with limited adverse events. However, in moderate-to-severe HS, RF has failed to yield satisfactory results.RESULTSOut of 55 identified studies, 11 met our inclusion criteria with 167 subjects who underwent RF therapy alone or combined with an intense pulsed laser (IPL), known as LAight®. LAight® significantly improved clinical outcomes in mild-to-moderate HS patients based on the Dermatology Life Quality Index (DLQI), International Hidradenitis Suppurativa Score System (IHS4), Pain-Numerical Rating Scale (NRS), and Hidradenitis Suppurativa Clinical Response (HiSCR). Moreover, RF therapy alone significantly alleviated the clinical manifestations in patients with mild-to-moderate HS. Additionally, fractional microneedling RF significantly decreased HS-associated inflammatory markers. RF was found to be safe with limited adverse events. However, in moderate-to-severe HS, RF has failed to yield satisfactory results.RF is a safe energy-based method with promising outcomes, especially for long-term application in mild-to-moderate HS. In moderate-to-severe cases, RF should be combined with a systemic medication for further beneficial impacts.CONCLUSIONRF is a safe energy-based method with promising outcomes, especially for long-term application in mild-to-moderate HS. In moderate-to-severe cases, RF should be combined with a systemic medication for further beneficial impacts. Background and aimsHidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a minimally invasive method that acts by minimizing thermal damage to the dermis, resulting in collagen synthesis and scar improvement. We systematically reviewed the efficacy and safety of RF in treating HS.MethodsA systematic search was performed up to November 18th, 2023, in PubMed/Medline, Ovid Embase, and Web of Science. Clinical studies with English full texts were included. The National Institute of Health (NIH) Quality Assessment Tool for clinical trials and Methodological quality and synthesis of case series and case reports by Murad et al. were utilized for critical appraisal.ResultsOut of 55 identified studies, 11 met our inclusion criteria with 167 subjects who underwent RF therapy alone or combined with an intense pulsed laser (IPL), known as LAight®. LAight® significantly improved clinical outcomes in mild-to-moderate HS patients based on the Dermatology Life Quality Index (DLQI), International Hidradenitis Suppurativa Score System (IHS4), Pain-Numerical Rating Scale (NRS), and Hidradenitis Suppurativa Clinical Response (HiSCR). Moreover, RF therapy alone significantly alleviated the clinical manifestations in patients with mild-to-moderate HS. Additionally, fractional microneedling RF significantly decreased HS-associated inflammatory markers. RF was found to be safe with limited adverse events. However, in moderate-to-severe HS, RF has failed to yield satisfactory results.ConclusionRF is a safe energy-based method with promising outcomes, especially for long-term application in mild-to-moderate HS. In moderate-to-severe cases, RF should be combined with a systemic medication for further beneficial impacts. |
| ArticleNumber | 139 |
| Author | Heidari, Nazila Ghane, Yekta Lotfi, Zahra Jaffary, Fariba Aghamiri, Zahra Sadat Nobari, Niloufar Najar Heidari, Amirhossein Hosseini, Seyedayin Nobari, Minou Najar Nilforoushzadeh, Mohammad Ali |
| Author_xml | – sequence: 1 givenname: Mohammad Ali orcidid: 0000-0001-6143-8039 surname: Nilforoushzadeh fullname: Nilforoushzadeh, Mohammad Ali organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley, Skin and Stem Cell Research Center, Tehran University of Medical Sciences – sequence: 2 givenname: Nazila orcidid: 0000-0001-7259-4926 surname: Heidari fullname: Heidari, Nazila organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, School of Medicine, Iran University of Medical Sciences – sequence: 3 givenname: Amirhossein orcidid: 0000-0003-4327-8814 surname: Heidari fullname: Heidari, Amirhossein organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University – sequence: 4 givenname: Yekta orcidid: 0000-0002-7309-4066 surname: Ghane fullname: Ghane, Yekta organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, School of Medicine, Tehran University of Medical Sciences – sequence: 5 givenname: Seyedayin orcidid: 0000-0003-3221-2270 surname: Hosseini fullname: Hosseini, Seyedayin organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley, School of Medicine, Shahid Beheshti University of Medical Sciences – sequence: 6 givenname: Zahra orcidid: 0009-0003-2468-9877 surname: Lotfi fullname: Lotfi, Zahra organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley – sequence: 7 givenname: Fariba orcidid: 0000-0002-9378-9738 surname: Jaffary fullname: Jaffary, Fariba organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley, Skin and Stem Cell Research Center, Tehran University of Medical Sciences – sequence: 8 givenname: Minou Najar orcidid: 0009-0000-3010-3543 surname: Nobari fullname: Nobari, Minou Najar organization: Department of Orofacial Pain and Dysfunction, UCLA School of Dentistry – sequence: 9 givenname: Zahra Sadat orcidid: 0009-0008-6544-7512 surname: Aghamiri fullname: Aghamiri, Zahra Sadat organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley, School of Medicine, Iran University of Medical Sciences – sequence: 10 givenname: Niloufar Najar orcidid: 0000-0002-4245-1980 surname: Nobari fullname: Nobari, Niloufar Najar email: niloufarnajarnobari.md@gmail.com, niloofar.nobari@yahoo.com organization: Skin Repair Research Center, Shahid Beheshti University of Medical Sciences, Ahmadi Alley, Skin and Stem Cell Research Center, Tehran University of Medical Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38795173$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUtLJTEQhcOgjI-ZP-BiCMzGTWul00n6MqtBfIHgRsFdSCcVjdxO30nSDvffT_QqDi5cVYp8pzhVZ49sxSkiIQcMjhiAOs4MGPAG2q6BDpRq4AvZZR0XjYTubuu_9w7Zy_kRgCnJ-Feyw3u1EEzxXXJ_6n2wxq6piY5m47Gs6eRpMi5MPuGfGWP9DJGWB6QloSkjxvKMPARXKYyhhEzzvFrNyZTwZH5RQ_M6Fxxra2nCp4B_v5Ftb5YZv7_WfXJ7dnpzctFcXZ9fnvy-aixXojSy6xCFkCBb6NyiF7hAIwfpFQKgbBkOYnCmbw1DNbjBOUTvrOUSey9awffJ4WbuKk3Vey56DNnicmkiTnPWHCRw1dajVPTnB_RxmlOs7l4okAJaWakfr9Q8jOj0KoXRpLV-O2EF-g1g05RzQq9tKHXzKZZkwlIz0M9p6U1auqalX9LSUKXtB-nb9E9FfCPKFY73mN5tf6L6ByR7qDM |
| CitedBy_id | crossref_primary_10_3390_ijms251910663 |
| Cites_doi | 10.4103/jdds.jdds_36_19 10.3390/cimb45050280 10.1046/j.1524-4725.2003.29081.x 10.1016/j.biocel.2012.05.007 10.1016/j.jaad.2019.02.068 10.1111/j.1524-4725.2007.34025.x 10.1016/j.addr.2018.06.019 10.1016/j.amsu.2021.102679 10.2340/00015555-3558 10.1111/jdv.15233 10.1007/s13555-023-00957-5 10.1080/01478885.2020.1861924 10.1136/bmj.n71 10.3390/cells10082094 10.1111/j.1365-2133.2011.10254.x 10.1136/bmjebm-2017-110853 10.1016/j.jaad.2015.07.050 10.1111/j.0906-6705.2004.00166.x 10.3390/ijms23179716 10.1159/000524739 10.3389/fphar.2021.746396 10.1046/j.1523-1747.2003.12043.x 10.1080/09546634.2019.1677842 10.36849/JDD.6562 10.1002/bjs.1800740535 10.1111/ced.14905 10.3390/jcm11237240 10.1016/j.jaad.2010.07.010 10.3390/clinpract11010005 10.1016/j.intimp.2023.111435 10.1111/srt.13450 10.1038/s41572-020-0149-1 10.1016/j.jaad.2016.08.001 10.1002/hsr2.1576 10.2147/CCID.S111019 10.3389/fimmu.2018.02965 10.1097/DSS.0000000000003477 10.1002/lsm.20687 10.1093/bjd/ljad229 10.1111/j.1524-4725.2009.01380.x 10.1159/000518540 10.1016/j.jid.2016.04.036 10.3389/fimmu.2021.670398 10.3390/ijms23073753 10.3390/biom12101371 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature. Copyright Springer Nature B.V. Dec 2024 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature. – notice: Copyright Springer Nature B.V. Dec 2024 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7SP 7U5 8FD FR3 H8D K9. L7M NAPCQ P64 7X8 |
| DOI | 10.1007/s10103-024-04077-0 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Electronics & Communications Abstracts Solid State and Superconductivity Abstracts Technology Research Database Engineering Research Database Aerospace Database ProQuest Health & Medical Complete (Alumni) Advanced Technologies Database with Aerospace Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Aerospace Database Nursing & Allied Health Premium Biotechnology Research Abstracts Technology Research Database Electronics & Communications Abstracts ProQuest Health & Medical Complete (Alumni) Solid State and Superconductivity Abstracts Engineering Research Database Advanced Technologies Database with Aerospace Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Aerospace Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Engineering Dentistry |
| EISSN | 1435-604X |
| ExternalDocumentID | 38795173 10_1007_s10103_024_04077_0 |
| Genre | Systematic Review Journal Article |
| GroupedDBID | --- -53 -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 36B 4.4 406 408 409 40D 40E 53G 5GY 5VS 67Z 6NX 7RV 7X7 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARAPS ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BENPR BGNMA BHPHI BSONS CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBLON EBS EIOEI EMB ESBYG F5P FEDTE FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HCIFZ HF~ HG5 HG6 HMJXF HQYDN HRMNR HVGLF HZ~ I09 IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M4Y MA- NB0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM P19 P2P P9S PF0 PT4 PT5 QOK QOR QOS R89 R9I RHV RNS ROL RPX RRX RSV S16 S27 S37 S3B SAP SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UOJIU UTJUX VC2 W23 W48 WJK WK8 YLTOR Z45 Z7U Z7V Z7W Z7X Z83 Z87 ZMTXR ZOVNA ~A9 ~EX 8FE 8FG 8FH AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ABUWG ACSTC AEZWR AFDZB AFHIU AFKRA AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA BBNVY BGLVJ BKEYQ BPHCQ BVXVI CITATION EBD EMOBN EX3 FYUFA I-F LK8 M7P MK0 NAPCQ P62 PQQKQ PROAC PSQYO PUEGO Q2X SV3 UKHRP WOW 8FI CGR CUY CVF ECM EIF M1P NPM 7QO 7SP 7U5 8FD FR3 H8D K9. L7M P64 7X8 |
| ID | FETCH-LOGICAL-c375t-644ee55606204d985e9ea6b6f7e00e621eb5bda82a1e7bdbddeefdcc36e8f5253 |
| IEDL.DBID | U2A |
| ISSN | 1435-604X 0268-8921 |
| IngestDate | Sat Sep 27 19:10:45 EDT 2025 Tue Oct 07 05:35:43 EDT 2025 Sun Jul 13 01:33:18 EDT 2025 Thu Apr 24 23:01:17 EDT 2025 Wed Oct 01 03:47:13 EDT 2025 Fri Feb 21 02:37:28 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Intense pulsed light Systematic review HS Hidradenitis suppurativa Radiofrequency |
| Language | English |
| License | 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c375t-644ee55606204d985e9ea6b6f7e00e621eb5bda82a1e7bdbddeefdcc36e8f5253 |
| Notes | ObjectType-Article-1 ObjectType-Evidence Based Healthcare-3 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Review-4 content type line 23 |
| ORCID | 0009-0003-2468-9877 0000-0002-4245-1980 0000-0002-7309-4066 0000-0003-3221-2270 0009-0008-6544-7512 0000-0001-7259-4926 0000-0002-9378-9738 0000-0001-6143-8039 0000-0003-4327-8814 0009-0000-3010-3543 |
| PMID | 38795173 |
| PQID | 3060065026 |
| PQPubID | 46654 |
| ParticipantIDs | proquest_miscellaneous_3060372604 proquest_journals_3060065026 pubmed_primary_38795173 crossref_citationtrail_10_1007_s10103_024_04077_0 crossref_primary_10_1007_s10103_024_04077_0 springer_journals_10_1007_s10103_024_04077_0 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-05-25 |
| PublicationDateYYYYMMDD | 2024-05-25 |
| PublicationDate_xml | – month: 05 year: 2024 text: 2024-05-25 day: 25 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England – name: Heidelberg |
| PublicationTitle | Lasers in medical science |
| PublicationTitleAbbrev | Lasers Med Sci |
| PublicationTitleAlternate | Lasers Med Sci |
| PublicationYear | 2024 |
| Publisher | Springer London Springer Nature B.V |
| Publisher_xml | – name: Springer London – name: Springer Nature B.V |
| References | R Sabat (4077_CR9) 2020; 6 HH van der Zee (4077_CR11) 2011; 164 F Anduquia-Garay (4077_CR1) 2021; 68 4077_CR30 A Vossen (4077_CR33) 2018; 9 NM Fragoso (4077_CR45) 2023; 13 N Mehta (4077_CR29) 2022; 48 JC Dalrymple (4077_CR44) 1987; 74 AH Fischer (4077_CR39) 2017; 76 4077_CR19 C Ertus (4077_CR40) 2023; 189 C Schlapbach (4077_CR10) 2011; 65 A Lyons (4077_CR23) 2022; 21 A Pol (4077_CR32) 2003; 120 U Kirschner (4077_CR26) 2020; 24 S Kawana (4077_CR46) 2010; 36 S Sodagar (4077_CR4) 2023; 6 J Li (4077_CR41) 2021; 12 M Schultheis (4077_CR22) 2022; 238 AJ Bodkin (4077_CR12) 2021; 44 MJ Page (4077_CR18) 2021; 372 MJ Diaz (4077_CR34) 2023; 45 CC Zouboulis (4077_CR6) 2019; 33 JH Yang (4077_CR16) 2022; 47 MH Murad (4077_CR21) 2018; 23 M Schultheis (4077_CR25) 2021; 11 J Ruiz-Esparza (4077_CR14) 2003; 29 A Alikhan (4077_CR13) 2019; 81 T Verrier (4077_CR31) 2012; 44 BM Hantash (4077_CR48) 2009; 41 M Napolitano (4077_CR3) 2017; 10 M Schultheis (4077_CR17) 2022; 238 R Gniadecki (4077_CR36) 2004; 13 4077_CR8 P Rousselle (4077_CR37) 2019; 146 4077_CR28 L Ocker (4077_CR5) 2022; 11 4077_CR7 4077_CR2 S Wilden (4077_CR24) 2021; 32 C Hotz (4077_CR35) 2016; 136 4077_CR20 4077_CR42 A Heidari (4077_CR38) 2024; 127 IH Hamzavi (4077_CR43) 2015; 73 SW Dunbar (4077_CR47) 2015; 14 J Iwasaki (4077_CR15) 2008; 34 4077_CR27 |
| References_xml | – volume: 24 start-page: 133 issue: 2 year: 2020 ident: 4077_CR26 publication-title: J Dermatol Dermatol Surg-Jdds doi: 10.4103/jdds.jdds_36_19 – volume: 45 start-page: 4400 issue: 5 year: 2023 ident: 4077_CR34 publication-title: Curr Issues Mol Biol doi: 10.3390/cimb45050280 – volume: 29 start-page: 333 issue: 4 year: 2003 ident: 4077_CR14 publication-title: Dermatol Surg. doi: 10.1046/j.1524-4725.2003.29081.x – volume: 44 start-page: 1377 issue: 8 year: 2012 ident: 4077_CR31 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2012.05.007 – volume: 81 start-page: 91 issue: 1 year: 2019 ident: 4077_CR13 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2019.02.068 – volume: 34 start-page: 114 issue: 1 year: 2008 ident: 4077_CR15 publication-title: Dermatol Surg doi: 10.1111/j.1524-4725.2007.34025.x – volume: 146 start-page: 344 year: 2019 ident: 4077_CR37 publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2018.06.019 – volume: 68 start-page: 102679 year: 2021 ident: 4077_CR1 publication-title: Ann Med Surg doi: 10.1016/j.amsu.2021.102679 – ident: 4077_CR20 – ident: 4077_CR27 doi: 10.2340/00015555-3558 – volume: 33 start-page: 19 issue: 1 year: 2019 ident: 4077_CR6 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/jdv.15233 – volume: 13 start-page: 1699 issue: 8 year: 2023 ident: 4077_CR45 publication-title: Dermatol Ther doi: 10.1007/s13555-023-00957-5 – volume: 44 start-page: 80 issue: 2 year: 2021 ident: 4077_CR12 publication-title: J Histotechnol doi: 10.1080/01478885.2020.1861924 – volume: 372 start-page: n71 year: 2021 ident: 4077_CR18 publication-title: BMJ doi: 10.1136/bmj.n71 – ident: 4077_CR7 doi: 10.3390/cells10082094 – volume: 164 start-page: 1292 issue: 6 year: 2011 ident: 4077_CR11 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2011.10254.x – volume: 23 start-page: 60 issue: 2 year: 2018 ident: 4077_CR21 publication-title: BMJ Evid Based Med doi: 10.1136/bmjebm-2017-110853 – volume: 73 start-page: S78 issue: 5 Suppl 1 year: 2015 ident: 4077_CR43 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2015.07.050 – volume: 13 start-page: 361 issue: 6 year: 2004 ident: 4077_CR36 publication-title: Exp Dermatol doi: 10.1111/j.0906-6705.2004.00166.x – volume: 14 start-page: 1229 issue: 11 year: 2015 ident: 4077_CR47 publication-title: J Drugs Dermatol – ident: 4077_CR2 doi: 10.3390/ijms23179716 – volume: 238 start-page: 1092 issue: 6 year: 2022 ident: 4077_CR22 publication-title: Dermatology doi: 10.1159/000524739 – ident: 4077_CR19 – volume: 12 start-page: 746396 year: 2021 ident: 4077_CR41 publication-title: Front Pharmacol doi: 10.3389/fphar.2021.746396 – volume: 120 start-page: 301 issue: 2 year: 2003 ident: 4077_CR32 publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.2003.12043.x – volume: 32 start-page: 530 issue: 5 year: 2021 ident: 4077_CR24 publication-title: J Dermatolog Treat doi: 10.1080/09546634.2019.1677842 – volume: 21 start-page: 430 issue: 4 year: 2022 ident: 4077_CR23 publication-title: J Drugs Dermatol doi: 10.36849/JDD.6562 – volume: 74 start-page: 420 issue: 5 year: 1987 ident: 4077_CR44 publication-title: Br J Surg doi: 10.1002/bjs.1800740535 – volume: 47 start-page: 335 issue: 2 year: 2022 ident: 4077_CR16 publication-title: Clin Exp Dermatol doi: 10.1111/ced.14905 – volume: 11 start-page: 7240 issue: 23 year: 2022 ident: 4077_CR5 publication-title: J Clin Med doi: 10.3390/jcm11237240 – volume: 65 start-page: 790 issue: 4 year: 2011 ident: 4077_CR10 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2010.07.010 – volume: 11 start-page: 26 issue: 1 year: 2021 ident: 4077_CR25 publication-title: Clin Pract doi: 10.3390/clinpract11010005 – volume: 127 start-page: 111435 year: 2024 ident: 4077_CR38 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2023.111435 – ident: 4077_CR28 doi: 10.1111/srt.13450 – volume: 6 start-page: 18 issue: 1 year: 2020 ident: 4077_CR9 publication-title: Nat Rev Dis Prim doi: 10.1038/s41572-020-0149-1 – volume: 76 start-page: 309 issue: 2 year: 2017 ident: 4077_CR39 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2016.08.001 – volume: 6 start-page: e1576 issue: 9 year: 2023 ident: 4077_CR4 publication-title: Health Sci Rep doi: 10.1002/hsr2.1576 – volume: 10 start-page: 105 year: 2017 ident: 4077_CR3 publication-title: Clin Cosmet Investig Dermatol doi: 10.2147/CCID.S111019 – volume: 9 start-page: 2965 year: 2018 ident: 4077_CR33 publication-title: Front Immunol doi: 10.3389/fimmu.2018.02965 – volume: 48 start-page: 788 issue: 7 year: 2022 ident: 4077_CR29 publication-title: Dermatol Surg doi: 10.1097/DSS.0000000000003477 – volume: 41 start-page: 87 issue: 2 year: 2009 ident: 4077_CR48 publication-title: Lasers Surg Med doi: 10.1002/lsm.20687 – volume: 189 start-page: 368 issue: 4 year: 2023 ident: 4077_CR40 publication-title: Br J Dermatol doi: 10.1093/bjd/ljad229 – volume: 36 start-page: 52 issue: 1 year: 2010 ident: 4077_CR46 publication-title: Dermatol Surg doi: 10.1111/j.1524-4725.2009.01380.x – volume: 238 start-page: 476 issue: 3 year: 2022 ident: 4077_CR17 publication-title: Controlled Trial Dermatology doi: 10.1159/000518540 – volume: 136 start-page: 1768 issue: 9 year: 2016 ident: 4077_CR35 publication-title: J Invest Dermatol doi: 10.1016/j.jid.2016.04.036 – ident: 4077_CR42 doi: 10.3389/fimmu.2021.670398 – ident: 4077_CR8 doi: 10.3390/ijms23073753 – ident: 4077_CR30 doi: 10.3390/biom12101371 |
| SSID | ssj0017613 |
| Score | 2.387546 |
| SecondaryResourceType | review_article |
| Snippet | Background and aims
Hidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a... Hidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a minimally invasive... Background and aimsHidradenitis suppurativa (HS) is an inflammatory skin disease affecting apocrine gland-bearing sites of the body. Radiofrequency (RF) is a... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 139 |
| SubjectTerms | Acne Case reports Clinical trials Collagen Cysts Dentistry Dermatology Dermis Effectiveness Hidradenitis Suppurativa - radiotherapy Hidradenitis Suppurativa - surgery Hidradenitis Suppurativa - therapy Humans Lasers Medicine Medicine & Public Health Optical Devices Optics Patients Photonics Pulsed lasers Quality assessment Quality control Quality of Life Quantum Optics Radio frequency Radiofrequency Therapy - methods Review Article Science Skin diseases Synthesis Systematic review Treatment Outcome |
| Title | Efficacy and safety of radiofrequency in the treatment of hidradenitis suppurativa; a systematic review |
| URI | https://link.springer.com/article/10.1007/s10103-024-04077-0 https://www.ncbi.nlm.nih.gov/pubmed/38795173 https://www.proquest.com/docview/3060065026 https://www.proquest.com/docview/3060372604 |
| Volume | 39 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1435-604X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017613 issn: 1435-604X databaseCode: AFBBN dateStart: 19970301 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: ProQuest Technology Collection customDbUrl: eissn: 1435-604X dateEnd: 20241101 omitProxy: true ssIdentifier: ssj0017613 issn: 1435-604X databaseCode: 8FG dateStart: 20020101 isFulltext: true titleUrlDefault: https://search.proquest.com/technologycollection1 providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1435-604X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017613 issn: 1435-604X databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1435-604X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017613 issn: 1435-604X databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-2FLbuoWzZ2nptgwZ7Ww22ZPmDPYU1adnonhbonowsnbZAcUKcPOS_78lf6eha6LNPsvHdSb_j7n4H8DnOtELFYz-zUeBT_CXI5wjIhVpzih7SUAvX73z9M76aRd9v5E3bFFZ11e5dSrI-qe81u4Wu9oe7wokgSXwK1Peko_MiK57xcZ87oMBctO0x_1_37xX0AFc-yInWV830LRy0GJGNG6W-gxdYDuH1havrcaPZhvDmHovgEF5dt_nx9_Bn4hghlN4yVRpWKYvrLVtYtlJmvrCrpmx6y-YlI9zH-iJzJ_J3bkgKXS1RxarNcrmpOcHVV6bYju6ZNa0uH2A2nfz6duW3oxR8LRK59gn1IEpCN45-3mSpxAxVXMQ2wSDAmIdYyMKolKsQk8IUdOihNVqLGFMruRSHMCgXJR4DkyLDqEiyjBsToQyUFTazBdkCubIJpAdh93dz3fKMu3EXt_mOIdlpJCeN5LVG8sCDL_2aZcOy8aT0aae0vPW4KqfQp4abPPbgU_-YfMUlQFSJi00jIxKK4CIPjhpl968Tbup6mAgPzjvt7zZ__Fs-Pk_8BPZ5bYnS5_IUBuvVBs8I1ayLEbxMp5cj2Btf_v4xGdUmfQfuAfFi |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6hrUThwGN5BQoYiRukSuw42YhTBVsW2u2pK5VT5NhjWIGyq01yWH4947y2UEDqOZPEccb2N5pvvgF4HadaoeKxn9oo8Cn-ErTmCMiFWnOKHiahFq7eeX4WzxbR5wt50RWFlT3bvU9JNjv1pWK30HF_uCNOBEniU6C-F1GAwkewd_Txy8l0yB5QaC66Apm_3_n7IXQFWV7JijaHzfFdWPTDbDkm3w_rKj_UP_9QcLzud9yDOx36ZEetu9yHG1iMYf-DYwy5pm9juH1Jn3AMN-dd5v0BfJ06rQmlt0wVhpXKYrVlK8s2yixXdtMSsrdsWTBClGygrzuTb0tDVuhYSiUr6_W6btTG1Tum2E5ImrVFNA9hcTw9fz_zuyYNvhaJrHzCU4iScJMTtjfpRGKKKs5jm2AQYMxDzGVu1ISrEJPc5LSdojVaixgnVnIpHsGoWBX4BJgUKUZ5kqbcmAhloKywqc3Jy2iTMIH0IOz_WqY7BXPXSONHttNednOb0dxmzdxmgQdvhnvWrX7Hf60PemfIurVcZhRUNUCWxx68Gi7TKnSpFVXgqm5tREKxYeTB49aJhtcJ1889TIQHb3uH2D3832N5ej3zl7A_O5-fZqefzk6ewS3e-Jf0uTyAUbWp8Tlhpyp_0S2VX6ZMDsg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT9tAEB0hkCg9VBAKuHx0K3GjFvau147FCQERhYJ6IBI3a707C5GQEyXOIf--s7bjpKIgcfasbfnNeN9oZt4CHMepVqh47Kc2CnzKvwTFHBG5UGtO2UM31MLNO9_dx9f96OZRPi5N8Vfd7vOSZD3T4FSaivJ0ZOzp0uBb6PqAuGuiCJLEp6R9LXJCCeTRfX7e1hEoSRfNqMz_1_27Hb3imK_qo9W209uELw1fZOc1wFuwgkUHPl26Hh93TFsHPi8pCnZg_a6plW_D05VTh1B6xlRh2ERZLGdsaNlYmcHQjusW6hkbFIw4IGsbzp3J88CQFbq-ogmbTEejaaUPrs6YYgvpZ1aPvXyFfu_q4eLab45V8LVIZOkTA0KUxHScFL1JuxJTVHEe2wSDAGMeYi5zo7pchZjkJqcfIFqjtYixayWXYgdWi2GBe8CkSDHKkzTlxkQoA2WFTW1OfkFhbQLpQTj_upluNMfd0Rcv2UIt2SGSESJZhUgWeHDSrhnVihvvWh_MQcua6JtklAZV1JPHHvxoL1PcuGKIKnA4rW1EQtlc5MFuDXb7OOFOYA8T4cHPOfqLm7_9Lt8-Zv4d1v9c9rLfv-5v92GDV04pfS4PYLUcT_GQyE6ZH1X-_Bf7V_YQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+safety+of+radiofrequency+in+the+treatment+of+hidradenitis+suppurativa%3B+a+systematic+review&rft.jtitle=Lasers+in+medical+science&rft.au=Nilforoushzadeh%2C+Mohammad+Ali&rft.au=Heidari%2C+Nazila&rft.au=Heidari%2C+Amirhossein&rft.au=Ghane%2C+Yekta&rft.date=2024-05-25&rft.issn=1435-604X&rft.eissn=1435-604X&rft.volume=39&rft.issue=1&rft_id=info:doi/10.1007%2Fs10103-024-04077-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10103_024_04077_0 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1435-604X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1435-604X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1435-604X&client=summon |